Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US

References

• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7
   PubMed Web of Science ®Google Scholar
• Resnikoff S, Pascolini D, Etya’ale D,. et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82:844-51
   PubMed Web of Science ®Google Scholar
• Friedman DS, Wilson MR, Liebmann JM,. et al. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004; 138:S19-S31
   PubMed Web of Science ®Google Scholar
• Congdon N, O’Colmain B, Klaver CC,. et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85
   PubMed Web of Science ®Google Scholar
• Le A, Mukesh BN, McCarty CA, . et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003; 44:3783-9
   PubMed Web of Science ®Google Scholar
• Schwartz K, Budenz D., Current management of glaucoma. Curr Opin Ophthalmol 2004;15:119-26
   PubMedGoogle Scholar
• Kobelt G, Jonsson L, Gerdtham U, . et al. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany. Graefes Arch Clin Exp Ophthalmol 1998;236:811-21
   PubMed Web of Science ®Google Scholar
• Jonsson B, Krieglsten G. Primary open-angle glaucoma: differences in international treatment patterns and costs. Oxford: Isis Medical Media Ltd. 1998
   Google Scholar
• Kass MA, Gordon M, Morley RE Jr.,. et al. Compliance with topical timolol treatment. Am J Ophthalmol 1987;103:188-93
   PubMed Web of Science ®Google Scholar
• Primary Open-Angle Glaucoma. Preferred Practice Pattern. Online. American Academy of Ophthalmology. San Francisco: American Academy of Ophthalmology, 2005. Available at: http://www.aao.org/education/guidelines/ppp/poag_new.cfm [last accessed 29 January 2008]
   Google Scholar
• Ederer F, Gaasterland DA, Dally LG,. et al. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64
   PubMed Web of Science ®Google Scholar
• Reeder CE, Franklin M, Bramley TJ. Managed care and the impact of glaucoma. Am J Manag Care 2008;14:S5-S10
   PubMed Web of Science ®Google Scholar
• Kobelt-Nguyen G, Gerdtham UG, Alm A. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational 2-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma 1998;7:95-104
   PubMed Web of Science ®Google Scholar
• Traverso CE, Walt JG, Kelly SP,. et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005; 89:1245-9
   PubMed Web of Science ®Google Scholar
• Lee PP, Walt JG, Doyle JJ,. et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006;124:12-19
   PubMed Web of Science ®Google Scholar
• Kobelt G, Jonsson L. Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom. Int J Technol Assess Health Care 1999;15:207-19
   PubMed Web of Science ®Google Scholar
• Neelakantan A, Vaishnav HD, Iyer SA, . et al. Is addition of a third or fourth antiglaucoma medication effective?. J Glaucoma 2004;13:130-6
   PubMed Web of Science ®Google Scholar
• Kass MA, Heuer DK, Higginbotham EJ,. et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13
   PubMed Web of Science ®Google Scholar
• Lichter PR, Musch DC, Gillespie BW,. et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53
   PubMed Web of Science ®Google Scholar
• Althin R, Grima DT, Dhawan R, . et al. Considerations in developing model-based economic evaluations of glaucoma treatment. J Glaucoma 2006;15:541-7
   PubMed Web of Science ®Google Scholar
• Stewart WC, Stewart JA, Mychaskiw MA. Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye 2007; Aug 24. [Epub ahead of print]
   Google Scholar
• Stewart WC, Stewart JA, Nassar QJ, . et al. Cost-effectiveness of treating ocular hypertension. Ophthalmology 2008;115:94-8
   PubMed Web of Science ®Google Scholar
• Petitti DB. Advanced cost-effectiveness analysis. Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis Methods for Quantitative Synthesis in Medicine, 2nd edn. New York: Oxford University Press, 2000
   Google Scholar
• ReadyPrice® System. Thomson MICROMEDEX, 2007
   Google Scholar
• Rylander NR, Vold SD. Cost analysis of glaucoma medications. Am J Ophthalmol 2008;145:106-13
   PubMed Web of Science ®Google Scholar
• Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Can J Ophthalmol 2006; 41:449-56
   PubMed Web of Science ®Google Scholar
• Medicare Physician Fee Schedule 2007. Centers for Medicare and Medicaid Services. Baltimore: Centers for Medicare and Medicaid Services, 2006. Available at: http://www.cms. hhs.gov/PhysicianFeeSched/ [Last accessed 29 January 2008]
   Google Scholar
• Final Changes to the Hospital Outpatient Prospective Payment System and CY 2007 Payment Rates. Centers for Medicare and Medicaid Services. Baltimore: Centers for Medicare and Medicaid Services, 2006. Available at: http://www.cms.hhs. gov/HospitalOutpatientPPS/HORD/itemdetail.asp ?itemID= CMS1204971 [Last accessed 29 January 2008]
   Google Scholar
• Damji KF, Bovell AM, Hodge WG,. et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol 2006;90:1490-4
   PubMed Web of Science ®Google Scholar
• Spaeth GL, Baez KA. Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years. Arch Ophthalmol 1992;110:491-4
   PubMed Web of Science ®Google Scholar
• Schwartz AL, Love DC, Schwartz MA. Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma. Arch Ophthalmol 1985;103:1482-4
   PubMed Web of Science ®Google Scholar
• Krupin T, Patkin R, Kurata FK,. et al. Argon laser trabeculoplasty in black and white patients with primary open-angle glaucoma. Ophthalmology 1986;93:811-16
   PubMed Web of Science ®Google Scholar
• Shingleton BJ, Richter CU, Dharma SK,. et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology 1993;100:1324-9
   PubMed Web of Science ®Google Scholar
• Proposed Changes to the ASC Payment System and CY 2007 Payment Rate. Centers for Medicare and Medicaid Services. Baltimore: Centers for Medicare and Medicaid Services, 2006. Available at: http://www.cms.hhs.gov/ASCPayment/05_CMS-1932-P(ASC).asp [Last accessed 29 January 2008]
   Google Scholar
• Gold MR, Siegel JE, Russell LB, . et al. Cost-effectiveness in Health and Medicine. New York: Oxford University Press, 1996
   Google Scholar
• Parc CE, Johnson DH, Oliver JE,. et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001;132:27-35
   PubMed Web of Science ®Google Scholar
• TreeAge Software Inc. TreeAge Pro 2006 User's Manual. Online. 2006
   Google Scholar
• Alward WL., Medical management of glaucoma. N Engl J Med 1998;339:1298-307
   PubMed Web of Science ®Google Scholar
• Baudouin C, Rouland JF, Le Pen C. Changes in medical and surgical treatments of glaucoma between 1997 and 2000 in France. Eur J Ophthalmol 2003;13 Suppl 4:S53-60
   PubMed Web of Science ®Google Scholar
• Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology 2002;109:1372-6
   PubMed Web of Science ®Google Scholar
• Gricar JA, Wilson PR, Cave DG. Glaucoma. Manag Care Interface 1998;11:42-4
   PubMedGoogle Scholar
• Lee PP, Kelly SP, Mills RP,. et al. Glaucoma in the United States and Europe: predicting costs and surgical rates based upon stage of disease. J Glaucoma 2007; 16:471-8
   PubMed Web of Science ®Google Scholar
• Wilensky J, Fiscella RG, Carlson AM,. et al. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data. Am J Ophthalmol 2006;141:S28-S33
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Siegel JE, Gold MR,. et al. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-8
   PubMed Web of Science ®Google Scholar